Literature DB >> 6773903

Differences in the susceptibility of various aldose reductases to inhibition. II.

P F Kador, J H Kinoshita, W H Tung, L T Chylack.   

Abstract

The susceptibility of human lens aldose reductase (HLAR), human placental aldose reductase (HPAR), and rat lens aldose reductase (RLAR) to inhibition by 10 structurally diverse inhibitors is compared. Significant differences in the susceptibility of these enzymes was observed; however, no trends could be predicted. In general, HPAR appeared to be less susceptible to inhibition than either HLAR or RLAR, with the susceptibility of HLAR being more similar to RLAR than to HPAR. These findings indicate that the evaluation of aldose reductase inhibitors for potential clinical use may require the use of human aldose reductase from the appropriate target tissue.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6773903

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  6 in total

1.  Glucose-specific regulation of aldose reductase in capan-1 human pancreatic duct cells In vitro.

Authors:  J V Busik; S R Hootman; C A Greenidge; D N Henry
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

2.  Reduced Na+/K+ ATPase transport activity, resting membrane potential, and bradykinin-stimulated phosphatidylinositol synthesis by polyol accumulation in cultured neuroblastoma cells.

Authors:  M A Yorek; J A Dunlap; M R Stefani; E P Davidson
Journal:  Neurochem Res       Date:  1994-03       Impact factor: 3.996

3.  Dietary G-rutin suppresses glycation in tissue proteins of streptozotocin-induced diabetic rats.

Authors:  Takashi Nagasawa; Nobuaki Tabata; Yoshiaki Ito; Youichi Aiba; Naoyuki Nishizawa; David D Kitts
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

4.  Effect of a new aldose reductase inhibitor, (E)-3-carboxymethyl-5-[(2E)-methyl-3-phenylpropenylidene]rhodanine (ONO-2235) on peripheral nerve disorders in streptozotocin-diabetic rats.

Authors:  R Kikkawa; I Hatanaka; H Yasuda; N Kobayashi; Y Shigeta; H Terashima; T Morimura; M Tsuboshima
Journal:  Diabetologia       Date:  1983-04       Impact factor: 10.122

5.  In vitro antidiabetic potential of the fruits of Crataegus pinnatifida.

Authors:  S S Chowdhury; M N Islam; H A Jung; J S Choi
Journal:  Res Pharm Sci       Date:  2014 Jan-Feb

6.  Inhibition of Aldose Reductase by Ginsenoside Derivatives via a Specific Structure Activity Relationship with Kinetics Mechanism and Molecular Docking Study.

Authors:  Md Yousof Ali; Sumera Zaib; Susoma Jannat; Imtiaz Khan; M Mizanur Rahman; Seong Kyu Park; Mun Seog Chang
Journal:  Molecules       Date:  2022-03-25       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.